NCT04598360View on ClinicalTrials.gov

Release of Epoxyeicosatrienoic Acids From Erythrocytes During the Use of Extracorporeal Procedures (Heart-lung Machine)

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

January 1, 2022

Conditions
Coronary ArteriosclerosisValve Heart Disease
Interventions
PROCEDURE

Heart-Lung-Machine

blood sample before and during a single Heart-Lung-Machine procedure

Trial Locations (1)

13125

Charité University Experimental & Clinical Research Center, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT04598360 - Release of Epoxyeicosatrienoic Acids From Erythrocytes During the Use of Extracorporeal Procedures (Heart-lung Machine) | Biotech Hunter | Biotech Hunter